China Bct Pharmacy Group (OTC BB:CNBI)

Tuesday, January 12, 2010

Nine months ended
	September 30
	(Unaudited)
	2009			2008
Sales revenue	$	99,473,445		$	85,515,029
Cost of sales		72,944,350			63,331,372
Gross profit		26,529,095			22,183,657
Operating expenses
Administrative expenses		2,807,799			2,125,503
Research and development expenses		52,969			-
Selling expenses		2,577,153			1,458,392
		5,437,921			3,583,895
Income from operations		21,091,174			18,599,762
Interest income		65,902			28,813
Other income		70,754			69,087
Other expenses		(11,990	)		(103,545	)
Finance costs		(1,090,930	)		(988,436	)
Income before income taxes		20,124,910			17,605,681
Income taxes		(4,748,741	)		(4,018,843	)
Net income	$	15,376,169		$	13,586,838
Other comprehensive income
Foreign currency translation
Adjustments		25,143			1,046,791
Total comprehensive income	$	15,401,312		$	14,633,629

____________________________________________________________________________

Year Ended
	December 31,
	2008			2007			2006
Sales revenue	$	108,991,329		$	66,359,554		$	32,020,449
Cost of sales		79,361,987			53,307,827			25,212,469
Gross profit		29,629,342			13,051,727			6,807,953
Operating expenses
Administrative expenses		3,341,605			1,954,536			1,673,242
Research and development expenses		763,995			-			-
Selling expenses		2,122,153			1,209,891			1,170,458
		6,227,753			3,164,427			2,843,700
Income from operations		23,401,589			9,887,300			3,964,253
Interest income		29,315			30,186			21,436
Other income		143,426			78,966			64,985
Finance costs		(1,260,290	)		(658,912	)		(512,329	)
Income before income taxes		22,314,040			9,337,540			3,557,181
Income taxes		(5,656,878	)		(3,161,419	)		1,235,124
Net income	$	16,657,162		$	6,176,121		$	2,322,057